NCT00851227View on ClinicalTrials.gov

Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Liver DiseaseHyponatremia
Interventions
DRUG

conivaptan hydrochloride

intravenous

Trial Locations (1)

33014

Miami

Sponsors
All Listed Sponsors
lead

Cumberland Pharmaceuticals

INDUSTRY